Stem Cell Stock News; Vitro (OTCQB: VODG) Appoints Accomplished Finance Executive to Its Advisory Board

GOLDEN, Colo. � June 2, 2011 (Investorideas.com Newswire) - Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma, is pleased to announce the appointment of Duane C. Knight, Jr., CPA, to its Scientific Advisory Board. While officially a Scientific Advisory Board, this group of individuals provides their scientific and business acumen to assist the Company in the achievement of its overall goals. Mr. Knight has more than twenty-five years' experience in consulting, accounting and corporate finance. He is presently Operational Chief Financial Officer of Neuromonics, Inc., a medical device company that manufactures and distributes an FDA-approved and patented device to treat tinnitus, ringing in the ears, to global markets. He has an accomplished record in business finance including partnership of a Denver, CO-based investment bank, CFO of another medical device firm and owner of a public accounting and consulting firm. Mr. Knight was brought in to assist in the ongoing business development activities of the Company, especially as related to turn-around to profitability and the achievement of sustained earnings growth and other relevant financial activities. Mr. Knight�s addition to Vitro�s management team complements and extends the technical and business expertise of its team that includes, in addition to Mr. Knight, two directors & officers who have extensive scientific and business experience together with two additional SAB members who provide scientific and business input to the Company.

From 2009 to the present, Mr. Knight is the Operational Chief Financial Officer of Neuromonics, Inc., a privately held Australian firm, that is one of the only firms to offer an FDA-approved treatment of tinnitus, an often debilitating condition with continual ringing in the ears without auditory input. He oversees operations, finance (including a $2-million fund raise), accounting, auditing interface, HR and administration, corporate governance and IT. From 2007 to 2009, he was a partner of Trinity Capital Services, LLC, a Denver, CO-based investment bank, where he headed up the life science practice, while directing FINRA compliance, numerous private placements into client firms and sell side M&A engagements. From 2002 to 2007, he was Chief Financial Officer and VP of Finance of Denver Biomedical, Inc., a medical device firm that developed a novel catheter for the treatment of excess fluid buildup in typically terminally ill cancer patients. During his tenure, his responsibilities included business development that yielded 25% CAGR and EBITA CAGR of 34%. He was also responsible for gaining coverage by private insurance (Aetna) and Medicare reimbursement. He led several significant transactions including exit of a venture partner, recapitalization with a private equity firm, debt refinancing and ultimately, sale of the company to Cardinal Health, Inc. He was retained by Cardinal Health, Inc. to complete post-acquisition finance and integration/transition activities. Prior to 2002, Mr. Knight established his own public accounting and consulting firm and performed finance operations for various public and private firms, and was a senior audit manager for Hein & Associates, LLP.
Mr. Knight said, "I am pleased to join Vitro�s SAB at this point of its development and plan to use my experience and my connections within the biomedical and financial industry to assist Vitro in attaining sustained profitability by leveraging the strong competitive advantages of its present line of stem cell-based products to capture of significant global market share. There is a dynamic growth opportunity within the stem cell sector due to the demonstrated abilities of stem cell technology to radically alter regenerative medicine through advanced treatments of numerous untreatable and under treated diseases, injuries and age-related degenerative conditions."
About Vitro Diagnostics, Inc.
Vitro Diagnostics, Inc. dba Vitro Biopharma (OTCQB: VODG) (http://www.vitrobiopharma.com), owns U.S. patents for production of FSH, immortalization of pituitary cells, and a cell line that produces beta islets for use in treatment of diabetes. Vitro also owns a pending international patent for generation of pluripotent stem cells. Vitro's mission is "Harnessing the Power of Cells™" for the advancement of regenerative medicine to its full potential. Vitro operates within a modern biotechnology manufacturing, R&D and corporate facility in Golden, Colorado. Vitro manufactures and sells "Tools for Stem Cell and Drug Development™", including human mesenchymal stem cells and derivatives, optimized media for stem cell self-renewal and lineage-specific differentiation. Vitro recently formed a strategic alliance with HemoGenix�, Inc. (http://www.hemogenix.com/) to jointly manufacture and distribute Lumenesc™ and LumiSTEM™ quantitative assays for determination of stem cell quality, potency and response to toxic agents.
Safe Harbor Statement
Certain statements contained herein and subsequent statements made by and on behalf of the Company, whether oral or written may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward looking statements are identified by words such as "intends," "anticipates," "believes," "expects" and "hopes" and include, without limitation, statements regarding the Company's plan of business operations, product research and development activities, potential contractual arrangements, receipt of working capital, anticipated revenues and related expenditures. Factors that could cause actual results to differ materially include, among others, acceptability of the Company's products in the market place, general economic conditions, receipt of additional working capital, the overall state of the biotechnology industry and other factors set forth in the Company's filings with the Securities and Exchange Commission. Most of these factors are outside the control of the Company. Investors are cautioned not to put undue reliance on forward-looking statements. Except as otherwise required by applicable securities statutes or regulations, the Company disclaims any intent or obligation to update publicly these forward looking statements, whether as a result of new information, future events or otherwise.
1. Market research data provided by BCC Research.
Contact:
Vitro Diagnostics, Inc.
Dr. James Musick, 303-999-2130
Chief Executive Officer
jim@vitrodiag.com

Vitro Diagnostics, Inc. dba Vitro Biopharma (OTCQB:VODG) is a profiled stem cell stock at Investorideas.com
Visit the VODG company profile on Investorideas.com

Request News and Info on VODG

Disclosure, Disclaimer/ Disclosure -Vitro Diagnostics, Inc. dba Vitro Biopharma (OTCQB:VODG) showcase stem cell stock, one month, $one thousand, April - May 2011

Mississippian Formation Oil and Gas Stock Trading Snapshot; (NYSE: CHK), (NYSE: DVN), (OTCBB: OEDV), (NYSE: RRC), (NYSE: SD)

Point Roberts, WA. June 2, 2011 (Investorideas.com Energy Newswire) - www.InvestorIdeas.com, a leader in sector research including oil and gas stocks, issues a trading snapshot on several of the Mississippian Formation oil and gas stocks recently in the news.

Mississippian Formation Sector Trading Snapshot

• Chesapeake Energy Corporation (NYSE: CHK ) trading at $30.71, up 0.32 (1.05%) 10:55AM EDT
• Devon Energy Corporation (NYSE: DVN ) trading at $83.25, up 0.48 (0.58%) 10:54AM EDT
• Osage Exploration and Development, Inc. (OTCBB: OEDV) trading at $0.28
• Range Resources Corporation (NYSE: RRC ) trading at $53.79, up 0.36 (0.67%) 10:55AM EDT
• SANDRIDGE ENERGY INC (NYSE: SD ) trading at $11.16, up 0.04 (0.36%) 10:55AM EDT

Market Snapshot

• Dow 12,281.89 -8.25 -0.07%
• NASDAQ 2,781.56 +12.37 +0.45%
• S&P 500 1,315.66 +1.11 +0.08%
• 10 Yr Bond (%) 2.9950% +0.0290
• Oil 100.48 +0.19 +0.19%
• Gold 1,534.80 -7.60 -0.49%

In a recent Q&A with Investorideas.com, Kim Bradford, President and CEO of Osage Exploration and Development, Inc. discusses the players in the Mississippian Formation;
"There are more than a dozen that I could name offhand. What is interesting is that in almost every case, it is Oklahoma based companies that are in this play. Ranging from very long term privately owned Oklahoma drillers such as Nadel & Gussman and Ceja, which date back to the 20's and 30's to Eagle Energy which was founded in 2009, all are finding success in the Horizontal Miss. The publicly traded companies such as Chesapeake Energy, Devon Energy, SandRidge Energy, and Range Resources with a combined market cap of almost $70 billion lend a tremendous amount of credence to the play by their very presence. It is fair to say that at least in SandRidge Energy's case, its commitment to the Oklahoma Mississippian play has totally transformed the company from a lackluster natural gas focused producer to one of the most dynamic mid sized oil companies in the market today, with a stock price performance to match that transformation going from $4 less than a year ago to roughly $12 today. If you go to their website, and you should, it is obvious that they largely credit the Horizontal Miss for that transformation.
The attribute that all the Horizontal Miss players seem to have, beyond the fact that they are almost unanimously Oklahoma companies with detailed local knowledge, is that they have been largely driven by people of conviction, ranging from most notably Tom Ward at SandRidge Energy to Loren Schmidt at Calyx, Charles Wickstrom and Shane Matson at Spyglass Energy, as well as Osage's own Greg Franklin, and many others. While the Mississippian formation has been known for decades, it took the ability to re-evaluate without prejudice, and move forward with conviction that the Mississippian could be an ideal candidate for horizontal exploitation.
Because the Mississippian is present in so many counties in Oklahoma, each of the companies involved are making unique contributions to the knowledge base. As an example, Pablo Energy and Eagle Energy of Oklahoma are in completely different areas of Oklahoma, use completely different drilling and completion techniques, but are helping us all to advance our knowledge and build efficiencies. Oklahoma is a fantastic place todrill for oil and these are fantastic people and companies to be working along beside.”
More aboutOsage (OTCBB: OEDV)
Osage Exploration and Development, Inc. ( OTCBB: OEDV)
Based in San Diego, California with production offices in Oklahoma City, Oklahoma, and executive offices in Bogotá, Colombia, Osage Exploration and Development, Inc. is an independent exploration and production company with interests in oil and gas wells and prospects in the US and Colombia. www.osageexploration.com
Follow (OTCBB: OEDV) on Twitter.com
http://twitter.com/#!/OsageOEDV
Visit the Osage (OTCBB: OEDV) company showcase profile at Investorideas.com
http://www.investorideas.com/CO/OEDV/
Company News:
Osage (OTCBB: OEDV) Joint Ventures Its 10,000 Acre Horizontal Mississippian Nemaha Ridge Project
Full News: http://www.investorideas.com/CO/OEDV/news/2011/05261.asp
Company Q&A: Q&A Interview with Kim Bradford, President and CEO of Osage (OTCBB: OEDV), Following News of Joint Venture with Slawson Exploration Company, Inc. and U.S. Energy Development Corporation
Full interview: http://www.investorideas.com/CO/OEDV/news/2011/05312.asp
Request news and trading alerts on OEDV
http://www.investorideas.com/Resources/Newsletter.asp
Research more oil and gas stocks with the oil and gas stock directory at Investorideas.com - lists over 600 stocks including Bakken stocks
http://www.investorideas.com/OGSN/Stock_List.asp
Disclaimer: Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Disclosure: OEDV is a paid advertising oil and gas company on Investorideas.com - Disclosure: (6 months starting May 24, 2011 thirty five hundred per month, 100,000 144 shares)
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp  
800-665-0411 - cvanzant@investorideas.com or dawn@investorideas.com
Source - Investorideas.com

Osage Exploration and Development, Inc. (OEDV.OB) is a showcase oil and gas stock on Investorideas.com
Visit the company showcase profile at Investorideas.com
Request news and stock alerts for Osage Exploration and Development, Inc. (OEDV.OB)
Disclosure: (6 months starting May 24, 2011 thirty five hundred per month, 100,000 144 shares)

Security Industry News; Visualant (OTCBB:VSUL) Subsidiary, TransTech Systems, Unveils BadgePros, New Technical Support Resource for Its Distribution Channel

SEATTLE - June 2, 2011 (Investorideas.com Defense Newswire) - Visualant, Inc. (OTCBB: VSUL), a pioneer provider of industry-leading identification solutions, is pleased to announce today that its subsidiary, TransTech Systems, has launched a new online Support Center. The new technical support website, www.BadgePros.com, was developed by TransTech to provide immediate access to technical support information and expertise for its North American reseller network.

With BadgePros, TransTech aims to equip their resellers with the ability to provide valuable support to users in the field while attracting new customers to TransTech Systems� industry-leading identification solutions.
"With a virtual technical resource center providing advice on both common and difficult technical issues, we will be able to help our customers diagnose and repair problems they are experiencing any time of the day," said Bill Ceccoli, one of TransTech�s certified technicians. "We can share our expertise with our customers, giving them access to information we have gained over years of experience working with these printers. Using our BadgePros Support Center even a dealer working on his first printer can diagnose and repair a problem."
Through weekly updates, TransTech Systems will provide information on cleaning, adjusting, updating, and repairing all of the leading ID printer brands including Evolis, HID, Magicard, Datacard, and NiSCA. Readers can also submit questions to the BadgePros blog for address in future topics. For access to this resource, visit the Support Center on http://www.ttsys.com/.
About Visualant, Inc.
Visualant, Inc. (OTCBB: VSUL) develops low-cost, high speed, light-based security and quality control solutions for use in homeland security, anti-counterfeiting, forgery/fraud prevention, brand protection and process control applications. Our patent-pending technology uses controlled illumination with specific bands of light, to establish a unique spectral signature for both individual and classes of items. When matched against existing databases, these spectral signatures allow precise identification and authentication of any item or substance. This breakthrough optical sensing and data capture technology is called Spectral Pattern Matching ("SPM"). SPM technology can be miniaturized and is easily integrated into a variety of hand-held or fixed mount configurations, and can be combined in the same package as a bar-code or biometric scanner.
Through its wholly owned subsidiary, TransTech Systems, Inc., the Company provides security and authentication solutions to security and law enforcement markets throughout the United States.
Contact:
Visualant, Inc.:
Lynn Felsinger
206 903 1351
Lynn@visualant.net
Investor Relations
Paul DeRiso
Core Consulting Group
925-465-6088
paul@coreconsultingroup.com
Visualant, Inc. (OTCBB:VSUL) Featured showcase company on Investorideas.com and related security portals and blogs
Visit the showcase page: http://www.investorideas.com/CO/VSUL/
Disclosure and Disclaimer: Visualant, Inc. (OTCBB:VSUL) is a paid advertising featured showcase company on Investorideas.com and related security portals and blogs.
(1500 per month and $five thousand per month in restricted 144 shares)

Biotech/Pharma Stocks News; UV Flu Technologies (OTCBB: UVFT) Announces Addition of Renowned Vice President of Sales

CENTERVILLE, MA - June 2, 2011 (Investorideas.com Newswire) - UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") is pleased to announce it has hired Denny Mulloy to assume the role of Executive Vice President of Sales, Marketing and Alliances for UV Flu, and its wholly owned subsidiary, Rx Air.

Mr. Mulloy has a long and distinguished career in various senior Sales and Marketing positions, with over 40 years experience with Fortune 100 companies such as NCR, Xerox, Dun and Bradstreet and I2 Technologies. During the course of his career, he was named the number one salesperson at both Xerox and Dun and Bradstreet Software. He has been serving as Chief Operating Partner for Blue Green Partners, a green technology and services company located in Dallas, Texas.
"We are thrilled to have someone of Denny's caliber join us," said Jack Lennon, President of UV Flu. "Over the last 6 months, we have purchased RX Air, paid off almost all our debt, added numerous distributors, domestically and internationally, refocused our entire marketing approach, while also rebranding our marketing materials. Denny's addition will enable us to efficiently address our newly created demand and growth opportunities. His focus on the Sales, Marketing and Alliances function will enable us to compress our timeline for the pending international distribution agreements, as well as additional domestic distributors. This strategic decision will accelerate our new product development, and enhancement plans."
"Seldom have I encountered an opportunity as ripe for growth as I see with UV Flu and RX Air," said Denny Mulloy, new Executive Vice President of Sales for UV Flu and RX Air. "This entire space is poised for growth, with much larger growth potential than what one would have seen 30 years ago before bottled water became popular. There is nothing more important to human health than the quality of the air we breathe 24 hours per day, but there is almost no attention or education being devoted to the sector. We are going to change this."
"The global impact to personal well being, and escalating health care costs are directly attributable to the significant rise in asthma, allergies, respiratory issues, and drug-resistant viruses. We're excited about the opportunity to enable people to live longer, healthier, and more productive lives, through the use of our proven, cost effective solutions. We're also confident of our ability to capture a healthy percentage, of what we think will become a $10 billion a year market over the next 5 years," said Mr. Mulloy.
Further details regarding the Company's business, acquisitions, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database. For more information, visit: www.uvflutech.com.
About UV Flu Technologies, Inc. (OTC.BB:UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector (over $7.7 billion in 2008). The Company manufactures the ViraTech UV-400, which utilizes high-intensity ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria, at rates exceeding 99.2% on a first-pass basis, while also reducing the concentrations of odors, and VOC's (volatile organic compounds, such as acetone, benzene, formaldehyde, etc.) The FDA has issued a coveted Class II medical listing that enables UV Flu Technologies to market the product as a medical device. For more information, visit: www.uvflutech.com. For sales: www.puravair.com.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.
John J. Lennon, President & CEO
Contact:
Investor Information:
Geaux IR Services, Inc.
Toll-Free: 1-888-355-8838
investors@uvflutech.com

SOURCE: UV Flu Technologies, Inc.
UV Flu Technologies (OTCBB: UVFT) is a showcase biotech stock on Investorideas.com (please read disclosure and disclaimers)
Visit the showcase page on Investorideas.com
http://www.investorideas.com/CO/UVFT/
Request info:
http://www.investorideas.com/Resources/Newsletter.asp

Frankfurt listed Wind Stock, City Windmills, Ltd. (CYW.F); Combines Clean Energy and Green Outdoor Advertising

June 2, 2011- Manchester, Lancashire, England, Switzerland, Point Roberts WA - Investorideas.com, a leader in cleantech investor research announces new showcase wind stock, City Windmills, Ltd. (Frankfurt: CYW.F Ticker: 3LWG41 / ISIN: GB00B3LWG419). The company is taking a unique approach in the wind markets, generating revenue from the production of clean energy from small wind turbines, in addition to green outdoor advertising.

City Windmills © was founded in early 2010 and has carried along its idea of building an efficient, enduring and cheap windmill, adapted for home use, for industrial level use and for larger sized wind farms. With City Windmills © and the low cost of production per kWh, any home can afford electricity at grid parity costs.
Several steps of developments allowed the City Windmill © system to evolve from producing energy at 0, 12 € (0, 14 US$) per kWh, then at 0, 09 € (0, 11 US$) per kWh and finally at 0,065 € (0, 08 US$) per kWh. This production cost, while amortizing the price of a City Windmill © over a period of 20 years (as for other power producing plants), is competitive with every other energy source. And this is achieved without any subsidies. In an unsubsidized environment, the payback can be as short as 4.5 years.
The company is targeting the $20 Billion outdoor advertising industry with a new concept in green outdoor advertising, combining clean energy technology and advertising.
City Windmills, Ltd. (CYW.F) is a company in the development phase, with the design, development and marketing of revolutionary small wind turbine systems clean flachblättrigen deals. The business model of Wind Mills City focuses on revenue generation from the production of clean energy from small wind turbines, along with advertising revenue. More info http://www.citywindmills.com/en/
Visit the profile for City Windmills, Ltd. (CYW.F)
http://www.investorideas.com/CO/CYW
View the company's presentation:
http://www.investorideas.com/CO/CYW/City-Windmills-Presentation-051811.pdf
CONTACT:
Sean Kelly, Chief Financial Officer
City Wind Mills, Ltd.
+41 22 310 8603
sean.kelly@citywindmills.com
Research other wind stocks with the renewable energy stocks directory
About Our Green Investor content:
Visit our showcase green stocks and research green stocks at: www.renewableenergystocks.com and http://www.investorideas.com/GI/
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Disclaimer/ Disclosure: City Windmills, Ltd. (CYW.F) is a paid advertising client on Investorideas.com and related blogs. (thirty five hundred per month, five thousand shares)
Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp , http://www.investorideas.com/About/News/Clientspecifics.asp
For more information contact:
D Van Zant 800.665.0411, Email: dawn@investorideas.com or Cali at cvanzant@investorideas.com
Source: www.Investorideas.com, City Windmills

City Wind Mills, Ltd.. (CYW.F) is a Frankfurt listed wind stock showcased on Investorideas.com and related green blogs
Visit the showcase profile for City Wind Mills, Ltd.. (CYW.F) to learn more
Request new, articles and trading alerts on City Wind Mills, Ltd.. (CYW.F)
Disclosure: City Wind Mills, Ltd. (CYW.F) is a paid advertising online client ( 6 months – thirty five hundred per month , five thousand shares)

Biotech/Medical Technology Stock News; Aethlon Medical (OTCBB: AEMD) President Rodney S. Kenley to Present at the 20th International Vicenza Course on Hemodialysis and CKD

SAN DIEGO – June 2, 2011 (Investorideas.com newswire) - Aethlon Medical, Inc. (OTCBB: AEMD) today announced that Company President Rodney S. Kenley will discuss the role of the Aethlon Hemopurifier® in the treatment of hepatitis C virus (HCV) in an upcoming presentation at the 20th International Vicenza Course of Hemodialysis and CKD (chronic kidney disease) on Wednesday, June 8, 2011 in Vicenza, Italy. The Aethlon Hemopurifier® is a first-in-class therapeutic filtration device that selectively removes infectious viruses and immunosuppressive toxins from the entire circulatory system through the use of dialysis machines and other blood circulatory pumps already located in hospitals and clinics worldwide.

Mr. Kenley's presentation, "The Treatment of HCV with Affinity Plasmapheresis on Dialysis Machines," will focus on treating HCV in existing dialysis clinics with no change in infrastructure or capital investments. The Hemopurifier® can be used to treat HCV in dialysis patients, in whom the prevalence of HCV is over 100 times higher than in the general population, as well as to treat non-dialysis patients.
"I am particularly honored to be asked to participate in this preeminent annual dialysis conference considering that my subject matter is a bit of a departure from the usual content of this meeting," said Mr. Kenley. "I believe that this is an indication of the gravity and prevalence of hepatitis C infections in the end-stage renal disease population and the interest the clinicians in this field have in learning about new approaches to this disease. Given Aethlon's intent to perform future clinical trials in Europe aimed at an eventual European regulatory approval, the opportunity to expose clinicians from all across Europe to our technology could prove to be very helpful when it comes time to recruit clinical investigators."
Human studies have documented the ability of the Hemopurifier® to safely reduce viral load in both HCV and human immunodeficiency virus (HIV) infected patients without the administration of antiviral drugs. The Company's clinical and early commercialization focus includes advancing the Hemopurifier® as an adjunct therapy to enhance the benefit of infectious disease and cancer treatment regimens. The Company's plan is to commercialize the Hemopurifier® in India as it advances clinical strategies in the United States and the European Union. Aethlon is currently conducting a clinical study at the recently opened, $360-million Medanta Medicity Institute near Delhi, India. A clinical goal of the study is to demonstrate that the Hemopurifier® accelerates early viral load reduction when combined with HCV standard of care drug regimens.
The 20th International Vicenza Course of Hemodialysis and CKD Course is organized in collaboration with the International Society of Nephrology and the Commission for the Global Advancement of Nephrology (COMGAN), in conjunction with the International Society of Hemodialysis. The Vicenza Course on hemodialysis is made in strict collaboration with the industry of the field.
About Aethlon Medical
At Aethlon Medical, we create revolutionary devices to address infectious disease and cancer. Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in disease diagnosis and monitoring.
We recently introduced the Aethlon ADAPT™ system, an adaptive dialysis-like affinity platform technology. Our platform technology allows marketed drugs, clinical-stage drugs and agents that previously failed clinical studies to be repurposed within a therapeutic filtration design that results in an expedited and less costly medical device pathway.
Our Hemopurifier® is the first medical device to selectively target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. We recently discovered that our Hemopurifier® captures tumor-secreted exosomes that suppress the immune system of those afflicted with cancer. Prior to this discovery, a therapeutic strategy to directly inhibit or reverse the immunosuppressive destruction caused by exosomes did not exist in cancer care. By eliminating this mechanism, we believe our Hemopurifier® can fill an unmet clinical need and provide the benefit of an immune-based therapy without adding drug toxicity or interaction risks to established and emerging treatment strategies.
In vitro studies conducted by government and non-government research institutes have also verified that our Hemopurifier® has broad-spectrum capabilities against bioterror and emerging pandemic threats. These studies have confirmed the capture of Dengue Hemorrhagic Virus, Ebola Hemorrhagic Virus, Lassa Hemorrhagic Virus, West Nile Virus, H5N1 Avian Influenza Virus, 2009 H1N1 Influenza Virus, the reconstructed Spanish Flu of 1918 Virus, and Monkeypox Virus, which serves as a model for human Smallpox infection.
As a therapeutic device, the Hemopurifier® provides us with a pipeline into four significant market opportunities:

1. Cancer: A treatment candidate to improve patient responsiveness to established cancer therapies by removing immunosuppressive exosomes from circulation.
2. Hepatitis-C Virus (HCV): As an adjunct therapy to accelerate viral load reduction at the outset of standard of care drug regimens.
3. Human Immunodeficiency Virus (HIV): Provides a potential therapeutic option for HIV-infected individuals to manage disease progression once they become resistant to antiviral drug regimens.
4. Bioterror and Pandemic Threats: Represents the most advanced broad-spectrum strategy to address untreatable bioterror and emerging pandemic threats.

The Hemopurifier® is an expansive multi-patented platform technology whose mechanism of action can be leveraged to provide therapeutic, diagnostic, and biomarker discovery solutions. As a therapeutic, the Hemopurifier® is a single-use disposable cartridge designed for implementation within the established infrastructure of dialysis machines and other blood circulatory pumps already located in hospitals and clinics worldwide.
In design, our Hemopurifier® is a selective filtration device containing affinity agents that tightly bind to high-mannose structures unique to the surface of exosomes produced by cancer and glycoproteins residing on the envelope of viruses. These agents are immobilized around approximately 2800 porous hollow fibers that run the interior length of our device. The resulting design provides us the novel ability to separate both exosome and viral targets away from blood cells so they can then be selectively and permanently removed from the circulatory system. In application, blood circulation is established into the Hemopurifier® via a catheter or other blood access device. Once blood flow has been established, treatment benefit is immediate as the entire circulatory system can pass through the Hemopurifier® in as little as 15 minutes.
Our wholly owned subsidiary, Exosome Sciences, Inc. (ESI) is focused on the development of exosome-targeted products and services that improve cancer diagnosis, provide post-treatment cancer surveillance, and aid in the discovery of biomarkers that allow doctors to optimize patient therapy. Additional information regarding Aethlon Medical and Exosome Sciences can be accessed online at www.aethlonmedical.com.
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the company's ability to commercialize its Hemopurifier® in India, capability of the Hemopurifier® to reduce viral loads and other disease conditions or to identify or treat disease conditions such as cancer or Hepatitis-C, including the ability to capture exosomes and the impact that potential ability may have on disease conditions, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.
Contacts:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
Jody Cain
Senior Vice President, Lippert/Heilshorn & Associates
310.691.7100
jcain@lhai.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
John P. Salvador
Director, Communications & Investor Relations
858.459.7800 x307
jps@aethlonmedical.com

AETHLON MEDICAL INC (OTC BB: AEMD) is a Showcase biotech, biodefense and defense stock on Investorideas.com ($one thousand five hundred per month, $five thousand per month in 144 stock)
Effective March 15, 2011

Biotech/Pharma Investor Trading Alert; BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) Moves to New Trading Levels Following Breakout of 52 Week High

Point Roberts, WA, LINCOLNSHIRE, Ill - June 1, 2011 - Investorideas.com, a leader in sector stock research for independent investors, issues a trading alert for specialty biotech/pharma stock, BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX). The stock has reached as high as $3.20 following yesterday's news of completing Phase III Safety Study for Biosante’s flagship product LibiGel®.
The five day trading chart shows the technical breakout of the 52 week high and reaching new highs.
Latest News: Pharma News; BioSante Pharmaceuticals (NASDAQ: BPAX) Completes Enrollment in LibiGel® Phase III Safety Study
May 31, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX), today announced completion of enrollment in its ongoing LibiGel (testosterone gel) Phase III cardiovascular and breast cancer safety study. LibiGel is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in menopausal women, for which there is no FDA-approved product.
BioSante has been informed by the LibiGel safety study independent Executive Committee regarding the outcome of the sample size analysis that determines the number of subjects to be enrolled in the LibiGel Phase III safety study. The FDA-agreed sample size analysis indicates that enrollment should stop, based on meeting a minimum 90 percent predictive probability of success of the safety study to show the safety of LibiGel at the primary data analysis. As per the protocol, the safety study will continue for 12 months of therapy from the last subject enrolled before the primary analysis will be conducted by BioSante, which will provide the data for BioSante's new drug application (NDA) submission anticipated to be made in 2012. The study will continue for five years.
Full News at: http://www.investorideas.com/CO/BPAX/news/2011/05311.asp
About BioSante Pharmaceuticals, Inc.

BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology.  BioSante’s lead products include LibiGel ® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment (SPA).  BioSante’s first FDA-approved product is Elestrin™ (estradiol gel) indicated for the treatment of hot flashes associated with menopause, marketed in the U.S. by Azur Pharma, BioSante’s licensee.  BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials.  Other BioSante products are Bio-T-Gel™, a testosterone gel for male hypogonadism, for which an NDA is pending, licensed to Teva Pharmaceuticals, and an oral contraceptive in Phase II clinical development using BioSante patented technology. Additional information is available online at: www.biosantepharma.com.
This article may contain forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include statements about BioSante’s plans, objectives, expectations and intentions with respect to future operations and products, future market acceptance, size and potential of LibiGel and other statements identified by words such as “will,” “potential,” “could,” “would,” “can,” “believe,” “intends,” “continue,” “plans,” “expects,” “anticipates,” “estimates,” “may,” other words of similar meaning or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante’s actual results to be materially different than those expressed in or implied by BioSante’s forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante’s licensees or sublicensees; the success of clinical testing; and BioSante’s need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante’s actual results are described in BioSante’s filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this presentation speak only as of the date of this presentation. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact BioSante:
For info about BioSante Pharmaceuticals, Inc
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
For Media:
McKinney/Chicago
Alan Zachary
(312) 506-5220
azachary@mckinneychicago.com
BioSante Pharmaceuticals, Inc: (NASDAQ: BPAX) is a featured showcase biotech/pharma stock on Investorideas.com
The full BPAX company profile is available at http://www.investorideas.com/CO/BPAX/ for interested biotech investors.
Request news, updates and trading alerts on BPAX and other showcase stocks http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com :
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including biotech and pharma stocks.
Disclaimer: The following news/content is paid for as part of the BPAX showcase program (two thousand per month) Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp  
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp  
Source: Investorideas.com, BioSante, Investorideas.com
Contact Investorideas.com
800 665 0411 cvanzant@investorideas.com

Wind Stock, Clean Wind Energy Tower, Inc. (OTCBB: CWET), Updates Shareholders on Patent Filings and Location of First Tower

ANNAPOLIS, MD � June 1, 2011 (InvestorIdeas.com Newswire) � Investorideas.com, a leader in cleantech investor research , reports that showcase wind stock, Clean Wind Energy Tower, Inc. (OTCBB: CWET), has updated shareholders with recent developments including patent filings and the location for the first downdraft wind tower.
News:
Clean Wind Energy Tower, Inc. (OTCBB: CWET) (the "Company") announced that the Company had communicated to their shareholders of record in a letter that stated: I wanted to take this opportunity to provide you with an update on our company, the recent merger transaction and the company's business plan moving forward.

In January of 2011, we notified shareholders of Superior Silver Mines, Inc., a publicly-traded company trading on the OTC Bulletin Board under the symbol "SSVM," that Clean Wind Energy Tower, Inc. (the "Company," "CWET") had completed what is commonly referred to as a "Reverse Merger" with their company with the surviving public entity being Clean Wind Energy Tower, Inc. In addition, "Clean Wind Energy, Inc." became a wholly-owned subsidiary of the Clean Wind Energy Tower, Inc. The business operations of Clean Wind Energy, Inc. will comprise the Company's principal business operations going forward. Clean Wind Energy, Inc.'s corporate headquarters are located at 1997 Annapolis Exchange Parkway Suite 300, Annapolis, Maryland 21401.
Effective January 24, 2011, the Company's quotation symbol on the Over-the-Counter Bulletin Board was changed from "SSVM" to "CWET." All matters pertaining to stock certificates and stock transfers are handled by our transfer agent:
Columbia Stock Transfer
601 E. Seltice Way, Ste. 202
Post Falls, ID 83854
Phone: (208) 664-3544
Fax: (208) 777-8998
Introducing Clean Wind Energy, Inc.
Clean Wind Energy, Inc. has assembled a world class team of experienced business professionals, engineers and scientists with access to the breakthrough energy research upon which this technology is founded and the proven ability to bring the idea to market. Clean Wind Energy, Inc. is designing and preparing to develop and construct large "Downdraft Towers" (the "Tower") that use benevolent, non-toxic natural elements to generate electricity and clean water economically by integrating and synthesizing numerous proven as well as emerging technologies. The Company has filed several patents that it believes will further enhance this potential revolutionary technology.
In addition to constructing Downdraft Towers in the United States and abroad, the Company intends to establish partnerships at home and abroad to propagate these systems and meet increasing global demand for clean water and electricity. The Company also plans to partner with a crane manufacturer for its construction needs and is in discussions with several potential partners for its hydraulic systems and generator needs.
Engineering Facility
Our engineering staff is located at our Engineering Office Facility located in Warrenton, Virginia. The engineering team is focused on the cultivation of innovative technological imperatives in addition to our already advanced wind energy structural designs and enhanced power generation methodologies. Part of their initial primary focus has been on the Company's intellectual property and patent filings.
Recent Patent Filings
CWET has filed a number of patents relating to both the construction and operating techniques for the Tower. We believe these patent applications provide enormous benefits and advantages to our Dual Renewable Energy solution by creating an additional multiple to our power base during the variety of atmospheric fluctuations in temperature, humidity and wind direction over the course of a season. These applications are but the first of many that we will file, focused on our leadership and value proposition for producing clean renewable fuel resources.
On March 7, 2011, the Company announced the filing with the United States Patent & Trademark Office "A Petition to Make Special Under Accelerated Examination Program," a patent application titled Efficient Energy Conversion Devices & Methods. The application covers specific aspects of deploying multiple turbines in a wind tunnel coupled to a novel hydraulic system capable of maintaining high efficiency hydraulic to electric conversion under a wide variance of wind speeds. The ultimate goal is to maximize the capture and utilization of all available wind energy in any given wind tunnel, as well as providing a consistency of power output during deviations in wind speed.
On May 3, 2011, the Company announced the filing with the United States Patent & Trademark Office "A Petition to Make Special Under the Accelerated Examination Program," a patent application titled Atmospheric Energy Extraction Devices and Methods. The application covers the addition of specific external design components, physical structure and systems that both substantially enhances structural integrity of the Tower and captures wind directly striking the external vertical surfaces of the downdraft Tower from any direction, beyond those winds already induced into the internal tube of the Tower, and also enhances slow moving air to create downburst winds, substantially increasing total power generation of a single Tower unit. A further description of all our patent filings appears on our website www.cleanwindenergytower.com.
Dual Renewable Energy Resource
The various external design and physical structural components work together to provide a Dual Renewable Energy Resource. The size of the Tower creates a tremendous sail area with the prevailing winds pressing against the Tower day and night. In order to stabilize the Tower, we designed large fins that structurally flow all the way to the ground. Those fins capture the prevailing wind and channel it down the side of the Tower into separate wind tunnels which drive turbines and make electricity. The fins take wind pressure loads off the Tower, making the Tower more structurally sound while at the same time capturing the renewable energy. That means we're making dual renewable energy from the exterior wind as well as the downdraft wind created inside the Tower.
Location for First Tower
We are, right now, working on the first site for a Tower and have completed the preliminary engineering for that location. We are performing and evaluating additional engineering and atmospheric studies related to the site and are hopeful that the results will provide us a suitable location for our first Tower project.
Investor Relations
Our corporate website has been updated with a new Investor Relations ("IR") section to better serve our shareholders and potential investors. The IR section will provide updates and information on our stock price, press releases, SEC filings, media coverage, and events and presentations. Feel free to register to receive our newsletters and follow us on Twitter and Facebook. Our IR contact is Mr. Jody Janson and he may be reached by emailing ir@CWETower.com or by calling (855) 848-6937.
In closing, I am very excited about the progress we have made in such a short period of time and would like to assure you that as an executive team, we are keenly focused on the development and execution of our Company's business plan. We invite you to watch for news regarding CWET's growth and the continued evolution of our Company. I would like to thank all of our shareholders for their support and commitment and look forward to updating you on our progress. Should anyone have any questions, please feel free to contact us anytime and we will be happy to speak with you.
Sincerely,
Ronald W. Pickett, President & CEO
Clean Wind Energy Tower, Inc.
About Clean Wind Energy, Inc. (OTCBB: CWET)
Clean Wind Energy, Inc., a wholly owned subsidiary of Clean Wind Energy Tower, Inc, is designing and preparing to develop, and construct large "Downdraft Towers" that use benevolent, non-toxic natural elements to generate electricity and clean water economically by integrating and synthesizing numerous proven as well as emerging technologies. In addition to constructing Downdraft Towers in the United States and abroad, the Company intends to establish partnerships at home and abroad to propagate these systems and meet increasing global demand for clean water and electricity. Clean Wind has assembled a team of experienced business professionals, engineers and scientists with access to the breakthrough energy research upon which this technology is founded and the proven ability to bring the idea to market. Clean Wind has filed several patents that the Company believes will further enhance this potentially revolutionary technology.
Cautionary Note Regarding Forward-Looking Statements
Statements included in this release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand and the Company's ability to obtain new contracts and accurately estimate net revenues due to variability in size, scope and duration of projects, and internal issues in the sponsoring client. Further information on potential factors that could affect the Company's financial results, can be found in the Company's various filings with the Securities and Exchange Commission (SEC).
Contact
Clean Wind Energy, Inc.
1997 Annapolis Exchange Parkway Suite 300
Annapolis, Maryland 21401
Phone: 410-972-4713
E-mail: Info@cwetower.com
www.cleanwindenergytower.com
Investor Relations
Jody Janson
Phone: (855) 848-6937
Email: ir@cwetower.com

Visit the CWET showcase page at Investorideas.com:
http://www.investorideas.com/CO/CWE/

Research more wind stocks with the renewable energy stocks directory:
http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp

About Investorideas.com and our Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.

Sign up at Investor Ideas for free investor alerts including news on wind stocks
http://www.investorideas.com/Resources/Newsletter.asp

Disclaimer/ Disclosure: The following news is part of the Clean Wind Energy Tower, Inc. (OTCBB: CWET) advertising program with Investorideas.com. Clean Wind Energy, Inc. compensates investorideas.com (one thousand five hundred per month, 100,000 144 shares) to be showcased as a renewable energy stock within its hub of sites and blogs.Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
For more information about Investorideas.com contact:
800.665.0411, Email: dvanzant@investorideas.com or cvanzant@investorideas.com

Investing in Clean Water; Wescorp Energy (OTCBB: WSCE) Performance Results for Second Generation H2Omaxx Water Remediation Unit

CALGARY - June 1, 2011 (Investorideas Water Newswire) - Wescorp Energy Inc. (OTCBB:WSCE), a clean water technology company focused on implementing cost-effective solutions in several markets, including the oil and gas and marine industries, recently announced the second generation 10,000 barrel per day (bpd) H2Omaxx technology has successfully treated marine bilge water.

The H2Omaxx achieved the International Maritime Organization approved Resolution MEPC 107(49) regulated maximum residual hydrocarbon clean water discharge of 15 parts per million (pap) with ease. This discharge standard is adopted and enforced nationally by agencies such as the U.S. Coast Guard.
"We are very impressed with the performance of the H2Omaxx in treating bilge water, which is a complex mix of hydrocarbons and other contaminants. The results of these real-world operations will be utilized in support of Allied Holdings and Wescorp Marine's development of the H2Omaxx for international marine certification and shipboard use through the Wescorp Marine joint venture," stated Tim Gale, President and CEO of Allied Holdings and President of Wescorp Marine. "This further supports our assessment that the H2Omaxx technology may be one of the best oil-water separation technologies available for shipboard use."
Bilge water was brought by barge from a ship to the H2Omaxx, where the water was treated and the hydrocarbons were separated and contained. Bilge water from ships contains a wide range of potential hydrocarbons and contaminants, including lube oil, fuel oil, machinery leakage, solvents, detergents, iron oxide particles, biological, equipment and engine-room wash water, firefighting foam, water treatment chemicals, grey water and sanitary system overflows, and seawater.
"Wescorp's objective is to demonstrate the capability of the H2Omaxx to meet the needs of an additional world-wide hydrocarbon based market, the marine industry," stated Robert G. Power, Executive Chairman of Wescorp's Board. "Now, we will move forward with Allied Holdings and Wescorp Marine to the next stage of development, technology adaptation and independent testing of H2Omaxx units for sea-going vessels."
Third party sampling of the bilge water before and after treatment, and reporting of the analytical results, was conducted by a national environmental consulting firm, hired by the bilge water service operator.
About Wescorp Energy Inc.
Wescorp (www.wescorpenergy.com) is a clean water technology company focused on implementing its superior, low-cost, water purification solutions for the oil and gas production industry and for marine remediation projects across North America. Wescorp's innovative clean technology is designed to meet increasing government regulations needs of our industry and society in general.
About Allied Holding Group
Allied (www.shipequip.com/aboutus.html) a closely held corporation since 1983 has paid careful attention to the requirements of the U.S. marine community from the standpoint of meeting specific needs with the U.S. Navy and U.S. Coast Guard, and ensuring that the products supplied comply with applicable standards and regulations. Allied's clients are manufacturers that seek to enter or expand their presence in the US public and private marine industry. Allied provides full market representation, product distribution, factory authorized repair facilities, and application engineering services. With an established reputation in the marketing and support of various marine equipment, Allied had secured business in excess of $450M for its principals.
About the H2Omaxx Technology
H(2)Omaxx utilizes proprietary next generation aeration technology to clean and separate oil and solids from water. It has been proven to be safe, effective, economical and an environmentally-friendly process. Independent test results have shown the H(2)0maxx technology will reduce the oil content in oil well produced water to less than 10 parts per million without the use of chemicals, filters or heat.
Safe Harbour Statement
Any statements contained herein that are not historical facts may be forward-looking statements. Forward-looking statements include statements regarding the intent, belief or current expectations of the Company, are based on certain assumptions, and involve known and unknown risks and uncertainties. Many factors could cause actual results to differ materially from those expressed or implied by the forward-looking statements. Information on the potential factors that could affect the Company's actual results of operations as well as other risks to the Company or its business may be further discussed in periodic reports and registration statements to be filed by the Company from time to time with the U.S. Securities and Exchange Commission.
To subscribe to our news releases and monthly newsletter, go to Wescorp's home page, www.wescorpenergy.com
Published at Investorideas.com
Investorideas.com creates a meeting place for investing ideas to take form and come to life in an entrepreneurial environment, servicing the needs of small investors and start- up companies to large conglomerates! We cover multiple industry sectors but specialize in environmental and water.

Become an Investor Ideas member and access our water stocks directory and all cleantech stock directories.

http://www.investorideas.com/Membership/

Sign up for free investor newsletters and stock alerts at Investor Ideas

http://www.investorideas.com/Resources/Newsletter.asp
Disclosure/disclaimer -All investment involves risk and possible loss of entire investment
Wescorp (OTCBB: WSCE is former paid advertising showcase stock by a third party; 2500 per month plus 100, 00 stock options at .25). Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. Compensation Disclosure and disclaimers: www.InvestorIdeas.com/About/Disclaimer.asp, http://www.investorideas.com/About/News/Clientspecifics.asp
Safe Harbour Statement
Any statements contained herein that are not historical facts may be forward-looking statements. Forward-looking statements include statements regarding the intent, belief or current expectations of the Company, are based on certain assumptions, and involve known and unknown risks and uncertainties. Many factors could cause actual results to differ materially from those expressed or implied by the forward-looking statements. Information on the potential factors that could affect the Company's actual results of operations as well as other risks to the Company or its business may be further discussed in periodic reports and registration statements to be filed by the Company from time to time with the U.S. Securities and Exchange Commission.

Woodford Shale Oil and Gas Stocks Sector Snapshot: (OTC.BB: AAPH), (NYSE: CHK), (NYSE: DVN), (NYSE: NFX), (NYSE: PHX)

Point Roberts WA - June 1, 2011 - www.Investorideas.com, a leader in sector research issues the following trading sector alert for oil and gas stocks with operations in the Woodford Shale play in Oklahoma. Oil and gas stocks include : American Petro-Hunter, Inc. (OTC.BB: AAPH), Chesapeake Energy Corporation (NYSE: CHK), Devon Energy Corporation (NYSE: DVN), Newfield Exploration Company (NYSE: NFX) and Panhandle Oil and Gas Inc (NYSE: PHX).
Drilling activity is one the rise in the area according to a recent article by PennEnergy.com – "Outpacing Louisiana for the number two spot, Oklahoma has the second-largest number of drilling rigs in the state with 173 active rigs. Most rigs are drilling in the Anadarko Basin, but some are active in the Arkoma Basin as well. Oklahoma has historically been a leader in natural gas production, but more rigs are drilling for oil in its liquids-rich Woodford Shale.”
http://www.pennenergy.com/index/petroleum/display/6379870995/articles/pennenergy/petroleum/exploration/2011/05/rig-counts_jump_as.html
Trading Snapshot (as of close May 31)

• American Petro-Hunter, Inc. (OTC.BB: AAPH) had a daily trading range of $0.47 - 0.55, closing at $0.50
• Chesapeake Energy Corporation (NYSE: CHK) closed at $31.34, up $ 0.23 (0.74%)
• Devon Energy Corporation (NYSE: DVN) closed at $84.07, up 0.73 (0.88%)
• Newfield Exploration Company (NYSE: NFX) closed at $74.59, up 0.44 (0.59%)
• Panhandle Oil and Gas Inc (NYSE: PHX) closed at $ 30.60, up $ 0.97 (3.27%)

Recent News from Woodford Shale Stocks:
Devon Energy Earns $416 Million in First-Quarter 2011; North American Onshore Production Increases 7 Percent
OKLAHOMA CITY, May 04, 2011
Cana-Woodford Shale Production Growth Leads Operating Highlights
•Production from the company's Cana-Woodford Shale play averaged a record 162 million cubic feet of natural gas equivalent per day in the first quarter of 2011. This represents a 120 percent increase compared to the first-quarter of 2010.
Full news: http://www.devonenergy.com/Newsroom/Pages/NewsRelease.aspx?id=1559196#terms?disclaimer=yes
Panhandle Oil and Gas Inc. Reports Second Quarter and Six Months 2011 Results...
May 6, 2011
"Drilling in the Southeast Oklahoma Woodford Shale is beginning to rebound as operators who purchased positions in the play over the past few years are beginning to accelerate the pace of drilling as reflected by the increasing number of well proposals...”
Full News: http://finance.yahoo.com/news/Panhandle-Oil-and-Gas-Inc-prnews-871690561.html?x=0&.v=1
American Petro-Hunter (OTCBB: AAPH) Updates Horizontal Drilling Progress at North Oklahoma Project
SCOTTSDALE , AZ - May 25, 2011 (Investorideas.com energy newswire) - American Petro-Hunter, Inc. (OTC.BB:AAPH) ("American Petro-Hunter" or the "Company") today wishes to update the drilling progress of the NOM1H Horizontal well at the Company's North Oklahoma Project. Full news:http://www.investorideas.com/CO/AAPH/news/2011/05251.asp
In a previously published Investorideas.com interview, Robert McIntosh, President & C.E.O. of American Petro-Hunter, Inc. (OTC.BB: AAPH) notes, "Shale plays for oil and gas are the new technology of the industry. Advancements in direction drilling and secondary recovery allow us to drill along these shales-they have oil it’s been found and is more of an engineering issue to extract it, like oil sands. So we will have known predictable oil and not have to "wildcat" hoping to discover oil. The Bakken is 200 feet thick and is worth billions to the companies involved. Our Oklahoma shale is new and we are on the cutting edge of drilling leasing and production. And the majors are there-Devon (NYSE: DVN ), Chesapeake, (NYSE: CHK ), Newfield (NYSE: NFX ) and others now producing gas from the Woodford shale in the south of the State.”
Read the full report on Shale stocks here:
http://www.investorideas.com/CO/AAPH/news/11151.asp
More info:
Visit the AAPH showcase profile at Investorideas.com
http://www.investorideas.com/CO/AAPH/
Request News and Info on AAPH
http://www.investorideas.com/Resources/Newsletter.asp
Disclosure, Disclaimer/ AAPH is a paid for advertising client on Investorideas.com- see below.
About American Petro-Hunter, Inc. (OTCBB: AAPH)
The Company is a goal-oriented exploration and production (E&P) Company aiming to become an intermediate level oil and gas producer within 12 months. The Company is in production at the Poston Project in Trego County Kansas with new drilling activity and production underway at the North Oklahoma Oil Project. With the achievable target of becoming a 1000 BOE producer as our goal, American Petro-Hunter is actively on the "hunt" for domestic petroleum assets. Visit us at: www.americanpetrohunter.com
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of our exploration program at our properties and any anticipated future production. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with petroleum exploration and development stage exploration companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-KSB for the most recent fiscal year, our quarterly reports on Form 10-QSB and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
Contact AAPH:
Investor Relations:
Mountainview IR Services, Inc.
1-888-521-7762
investors@americanpetrohunterinc.com
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including energy and mining stocks.
Sign up for the free investor news letter and get stock alerts in leading sectors! http://www.investorideas.com/Resources/Newsletter.asp
Research oil and gas stocks with the Investorideas.com energy stocks directory ;
http://www.investorideas.com/OGSN/Stock_List.asp
Disclaimer/ Disclosure: The following news is paid for and /or published as information only for our readers. American Petro-hunter Inc. (AAPH.OB is a paid showcase energy stock on Investorideas.com and all related energy portals and blogs (averaging tow thousand per month, paid by third party) Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of principal .
Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
www.Investorideas.com energy portals:
800-665-0411 or cvanzant@investorideas.com